ctDNA guided immunotherapy in patients with advanced non-small cell lung cancer: a nationwide Danish, randomised, intervention study (PRELUCA—PRediction in LUng CAncer Treatment) – study protocol
Authors
Melvin E. Andersen (ORCID: https://orcid.org/0000-0002-3894-4811)
Stine Wahlstrøm
Lise Barlebo Ahlborn (ORCID: https://orcid.org/0000-0001-8021-7442)
ctDNA guided immunotherapy in patients with advanced non-small cell lung cancer: a nationwide Danish, randomised, intervention study (PRELUCA—PRediction in LUng CAncer Treatment) – study protocol
Melvin E. Andersen, Stine Wahlstrøm, Lise Barlebo Ahlborn, Niels Pallisgaard et al.
Journal
BMJ Open
Topics
Cancer Genomics and Diagnostics
article
ctDNA guided immunotherapy in patients with advanced non-small cell lung cancer: a nationwide Danish, randomised, intervention study (PRELUCA—PRediction in LUng CAncer Treatment) – study protocol
Melvin E. Andersen, Stine Wahlstrøm, Lise Barlebo Ahlborn, Niels Pallisgaard, M.L. Frank, Maria Dalgaard Mikkelsen, Julie Gehl, Weronika Maria Szejniuk, Signe Timm, Christa Haugaard Nyhus, Malene Green Madsen
article en
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 16(2)
Institutions
Roskilde University (DK), University of Copenhagen (DK), University of Southern Denmark (DK), Region Zealand (DK), Aalborg University Hospital (DK), Rigshospitalet (DK), North Denmark Region (DK), Zealand University Hospital (DK), Vejle Sygehus (DK), Aalborg Portland (Denmark) (DK), Lillebaelt Hospital (DK), Capital Region of Denmark (DK), Aalborg University (DK)